Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018.
Enterococcus faecalis
Enterococcus faecium
MLST
Vancomycin resistance
vanA gene
vanB gene
Journal
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
ISSN: 1678-4405
Titre abrégé: Braz J Microbiol
Pays: Brazil
ID NLM: 101095924
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
11
06
2020
accepted:
04
08
2020
pubmed:
13
8
2020
medline:
22
7
2021
entrez:
13
8
2020
Statut:
ppublish
Résumé
A retrospective study of the epidemiology of vancomycin-resistant enterococci (VRE) in a regional hospital of central Italy in 2001-2018 demonstrated an increased VRE prevalence since 2016. A total of 113 VRE isolates, 89 E. faecium (VREfm) and 24 E. faecalis (VREfs), were collected in the study period. All strains showed high-level resistance to vancomycin; 107 also showed teicoplanin resistance. Altogether, 84 VREfm and 20 VREfs carried vanA, whereas 5 VREfm and 1 VREfs carried vanB. MLST analysis documented that 89 VREfm isolates mainly belonged to ST78, ST80, and ST117. Most strains were isolated from 2001 to 2007, ST78 being the predominant clone. VREfm re-emerged in 2016 with a prevalence of the ST80 lineage. Most VREfs were isolated from 2001 to 2006; although they belonged to 7 different STs, there was a prevalence of ST88 and ST6. Notably, ST88 was sporadically recovered throughout the study period. The increasing rate of VREfm isolation from 2016 to 2018 may be related to the influx of new successful clones and to the renewed and widespread use of vancomycin. Improved infection control measures in hospital wards should be adopted to limit the spread of new epidemic VRE strains.
Identifiants
pubmed: 32783169
doi: 10.1007/s42770-020-00360-8
pii: 10.1007/s42770-020-00360-8
pmc: PMC7688800
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1607-1613Références
Euro Surveill. 2019 Aug;24(34):
pubmed: 31456560
Emerg Infect Dis. 2005 Jun;11(6):821-8
pubmed: 15963275
J Clin Microbiol. 1995 Jan;33(1):24-7
pubmed: 7699051
Antimicrob Agents Chemother. 2015;59(6):3690-1
pubmed: 25824233
Microbiol Spectr. 2018 Jul;6(4):
pubmed: 30051804
Antimicrob Resist Infect Control. 2019 Aug 28;8:147
pubmed: 31485325
Antimicrob Resist Infect Control. 2018 Apr 24;7:54
pubmed: 29760912
Antimicrob Resist Infect Control. 2019 Jan 17;8:16
pubmed: 30675343
Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S5-12
pubmed: 16323120
J Antimicrob Chemother. 2016 Dec;71(12):3351-3366
pubmed: 27530756
J Antimicrob Chemother. 2019 Jul 1;74(7):1776-1785
pubmed: 30929020
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
Microb Drug Resist. 2018 Oct;24(8):1148-1155
pubmed: 29373085
J Antimicrob Chemother. 2016 Feb;71(2):307-13
pubmed: 26472766
J Med Microbiol. 2017 Dec;66(12):1744-1751
pubmed: 29134935
J Antimicrob Chemother. 2012 Mar;67(3):551-8
pubmed: 22207599
Microb Drug Resist. 2018 Jun;24(5):590-606
pubmed: 29058560
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62
pubmed: 30895215
Diagn Microbiol Infect Dis. 2007 Jun;58(2):163-70
pubmed: 17368801
Expert Rev Anti Infect Ther. 2014 Feb;12(2):239-48
pubmed: 24392717